George Clinical’s largest hub outside the head office of Sydney, offering full CRO services and a site network that spans the country.

George Clinical In China

China is George Clinical’s largest hub outside the head office of Sydney, offering full CRO services and a site network that spans the country.

With its large potential for patient recruitment and a rapidly growing pharmaceutical market, China – currently, the second largest in the world, is an obvious choice for many when entering the Asian market.

The Chinese healthcare delivery system consists of public hospitals and community healthcare centers, with an increasingly private care system. Recent NMPA (CFDA) changes in the regulatory environment have reinforced the need for quality data to be both verifiable and transparent with an increasing acceptance of ICH GCP standards. A complete overhaul of the regulatory process in July 2018 was undertaken to encourage innovation and shorten CTA approval times to 3 months. Additionally, truly innovative molecules may also apply for expedited approval shortening CTA approval times to as little as 2 months. A similar overhaul of the registration process has also been undertaken for medical devices and IVD products. These changes are significant and make China an increasingly attractive destination for trials.

George Clinical has been conducting clinical trials in China since 2007 with an extensive network of over 360 trial centers in 60 cities for Phase I-IV trials.

What are the benefits of conducting clinical trials in China?

  • China has access to a large patient pool
  • Potential for treatment naïve patients, especially in oncology
  • Rapidly developing medical infrastructure in urban centers and centers of excellence for many common diseases such as hypertension, diabetes, oncology, and renal disease
  • Lower operational costs

What are the most prevalent diseases in China?

  1. Stroke
  2. Ischaemic heart disease
  3. Chronic obstructive pulmonary disease
  4. Cancers
  5. Road injury
  6. Hypertension
  7. Diabetes mellitus
  8. Lower respiratory infections



Beijing - Main Office
Room 2305-2307, 23/F, GUORUI Plaza A, No.1 Ronghua SouthRoad Beijing Economic and Technological Development Area Beijing, China 100176 P.R. China
WeWork, Room17-107 China Overseas 838 S.Huangpi Road, TWR B Huangpu, Shanghai


Population 1.4 billion
Official Language Putonghua (Mandarin). Local dialects may be used
Hospital Records Language Simplified Chinese
Electronic Hospital Records Electronic records are used but not standardized across different provinces in China.
In-country services Beijing
Project Management, Clinical Operations, Data Management, Medical and Safety Services, Clinical Compliance, Regulatory Services, Statistics, Health Economics√ Shanghai
Medical & Safety Services, Project Management, Clinical Operation, B

Home-based Staff:
Changchun, Chengdu, Guangzhou, Harbin, Huai’an, Jinan, Nanchang, Nanjing, Nantong, Shenyang, Shenzhen, Shijiazhuang, Suzhou, Wuhan, Zhengzhou Clinical Operation, Project Management

Add George Clinical to your network